Morningstar4d
Currax Pharmaceuticals: Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA®
March 11, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a specialty pharmaceutical company and manufacturer of the #1 branded oral weight loss medication CONTRAVE® (naltrexone HCl ...
Currax Pharmaceuticals: Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA®
This peer-reviewed study, based on electronic health record data from more than 24,600 patients followed for over 4.7 years, found no e ...
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
The Victoria Advocate18d
Currax Provides Update on Litigation Against Found Health Inc.
Feb. 25, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a specialty pharmaceutical company and manufacturer of the #1 branded oral weight loss medication CONTRAVE ® (naltrexone HCl ...
NBC Washington4d
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.
Researchers discover another terrifying side effect caused by Ozempic that some only notice when it's too late
In the latest research, scientists from Canada tracked nearly 3,000 Americans who used either semaglutide, the active drug in ...